Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.38 USD | +3.03% | +3.61% | +38.79% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.79% | 3.89B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.07% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- HC Wainwright Adjusts Crinetics Pharmaceuticals Price Target to $50 From $42, Maintains Buy Rating